Biomarker-based treatment selection in early-stage rectal cancer to promote organ preservation

Background Total mesorectal excision (TME) remains commonplace for T1–2 rectal cancer owing to fear of undertreating a small proportion of patients with node‐positive disease. Molecular stratification may predict cancer progression. It could be used to select patients for organ‐preserving surgery if...

Ausführliche Beschreibung